Navigation Links
NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program
Date:5/6/2008

f NicOx S.A. to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Document de Reference filed with the AMF, which is available on the AMF website (http://www.amf-france.org) or on NicOx S.A.'s website (http://www.nicox.com).


'/>"/>
SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCal...nounced that Blair Lambert, CFO/COO, will present ...l be held at the May Fair Hotel in London, England...T. ,, To listen to a live broadcast of The Gymb... please log on to www.gymboree.com, click on "Our ...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNe...can professional cycling team dedicated to ethical...cling champions, announced today that it will beco...ansitions Optical as a new sponsor of the team. Tr...rer of adaptive eyewear, offering the most advance...
(Date:11/27/2009)... XenaCare Holdings has announ...rthritis Foundation, one of the largest nonprofit ...public health education. , ...naCare Holdings, Inc. (OTCBB: XCHO), a company spe... of consumer healthcare products, has announced to...
(Date:11/27/2009)...ing rates to bring unprecedented medical, economic.... 27 (HealthDay News) -- The number of people with...le over the next 25 years, a new study predicts. ,....1 million people with the disease, up from 23.7 m...treating people with diabetes will triple, the stu...
(Date:11/27/2009)... Voyant Health™ announc...gan) has licensed its TraumaCad Enterprise orthope...orkflow solution. , (PRWE...nced today that Spectrum Health (Grand Rapids, Mic...pedic templating solution and its TraumaCad Extend...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...ards, Find Inspiration in Video Blogs on,Determine...r,couple,s video blogs documenting their efforts t... Pennsylvania Department of Health,s new tobacco,c...to quit smoking together, not just for themselves,...
...eth Campaign to Eliminate Compounded Hormones, WA...mpounding Pharmacists (IACP) today called on the A...AACE) and the North American,Menopause Society (NA...nt. In recent weeks, AACE, NAMS and other supposed...
...dividuals or families may have underlying speech d...ews) -- People with a personal or family history o...rare type of dementia that causes them to lose lan... and progressively impaired, even though the perso...
...ith the recent announcement by,the United States F...ng,safety review of Botox Cosmetic (botulinum toxi...to treat frown lines between the brows. Botox(R),C... In its recent communication, the FDA reports adve...
...Healthcare Services,Inc. (NYSE: AHS ), the nation...oday that Hala Moddelmog, President and Chief Exec...joined the company,s Board of,Directors., "Hala b...ng president and strategic leader of a successful,...
... first PDP to conduct ePrescribing Pilot Study, F...s a bill that would tie physicians, Medicare payme... Health Solutions, Inc. (NYSE: MHS ) today,announ...escriptions. The pilot program will also be used t...
Other Medicine News:Health News:American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals 2Health News:Learning Disabilities May Presage Later Language Problems 2Health News:Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles 2Health News:AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 2Health News:AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 3Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 2Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 3Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 4
(Date:11/25/2009)...lif., Nov. 25 ChemoCentryx, Inc....from the Company,s PROTECT-1 (the Prospective Rand...Trial) of Traficet-EN(TM) (CCX282-B) in patients w...d clinical efficacy with a favorable safety and to...ce of clinical efficacy in the reduction of diseas...
(Date:11/24/2009)...Nov. 24 Endologix, Inc. ...treatments for aortic disorders, announced today t...all proceedings in, the patent infringement lawsui... The motion was filed in the United States Distri... has requested that the stay remain in effect whil...
(Date:11/24/2009)...24 Anadys Pharmaceutical...ill present at the 21st Annual Piper Jaffray Healt...:00 a.m. EST (6:00 a.m. PST). The conference is b...land, Ph.D., President and Chief Executive Officer... its clinical development programs, ANA598 and ANA...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Blood Tests May Spot Colon Cancer 58044 1Blood Tests May Spot Colon Cancer 58044 2Blood Tests May Spot Colon Cancer 58044 3Blood Tests May Spot Colon Cancer 58044 4Prix Galien USA to Launch a Health Care Dialogue Among World Leading Innovators in Science Economics and Biotech 58040 1Prix Galien USA to Launch a Health Care Dialogue Among World Leading Innovators in Science Economics and Biotech 58040 2SoluLinK Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100 25 Yields 14215 1SoluLinK Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100 25 Yields 14215 2
...wing the candidate vaccine induced neutralizing a...ERFIELD, Ill., June 11 Baxter International,Inc. ..., 2008 issue of The,New England Journal of Medicin...avian influenza (H5N1) vaccine, CELVAPAN, met Phas...ty (generating a functional immune,response). This...
...JOLLA, Calif., June 11 Duska Therapeutics,Inc. (O...), announced today,that it has been granted an exc... Johns Hopkins University to develop and commercia...l cardiovascular drugs for the,treatment of heart ...s,expected to enter a Phase II clinical study late...
Other Medicine Technology:The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine 2The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine 3The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine 4The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine 5Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins 2Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins 3
Siemens Webcast
Siemens Webcast: Legislative Developments Impacting Cardiology Services Reimbursement
...ny pH catheters are designed for patient comfort a...re number marked at 5cm intervals and line marked ...models are available spanning most clinical needs ...e models with one or two sensors., ,Flexilog sing...
...ny pH catheters are designed for patient comfort a...re number marked at 5cm intervals and line marked ...models are available spanning most clinical needs ...e models with one or two sensors., ,A range of fo...
Medicine Products: